AKT2 and breast cancer: In MDA-MB231 breast cancer cells treated with AKT isoform-specific siRNAs, prolonged suppression of the AKT2 isoform resulted G0/G1 cell cycle arrest through the downregulation of Cdk2 and cyclin D, and upregulation of p27 [35].